Key points are not available for this paper at this time.
The advent of blockchain technology has introduced a transformative paradigm in supply chain management, offering unprecedented transparency, traceability, and security. This paper explores the application of blockchain technology within the pharmaceutical industry, a sector notorious for its intricate supply chain networks and susceptibility to counterfeit products. By employing a distributed ledger system, blockchain ensures immutable records of transactions, facilitating seamless tracking of pharmaceutical products from manufacturer to end consumer. This abstract delves into the key features of blockchain, such as decentralization, cryptographic security, and smart contracts, elucidating their role in mitigating common challenges faced in pharmaceutical supply chains, including counterfeit drugs, regulatory compliance, and inefficient logistics. Moreover, the abstract examines case studies and pilot projects that have successfully integrated blockchain solutions, highlighting their tangible benefits in enhancing supply chain visibility, reducing operational costs, and fostering trust among stakeholders. As the pharmaceutical industry strives for greater efficiency and integrity in its supply chain operations, the adoption of blockchain technology emerges as a promising avenue for achieving these objectives. This abstract concludes by discussing future directions and potential challenges in the widespread implementation of blockchain within the pharmaceutical supply chain ecosystem.
Revathi et al. (Fri,) studied this question.